Replimune (REPL) Consolidated Net Income (2017 - 2026)
Replimune's Consolidated Net Income came in at -$56.92 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), compared with -$82.08 million a year earlier.
Powered by 
Analysis
Replimune (REPL) Consolidated Net Income (2017 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, Replimune reported Consolidated Net Income of -$269.89 million; for FY2026 (ended Mar 31, 2026), it was -$314.49 million.
- Going back by fiscal year, Consolidated Net Income was -$246.83 million in FY2025, -$215.39 million in FY2024, -$174 million in FY2023 and -$118.04 million in FY2022.
- The fiscal Q2 2027 figure represents the highest quarterly Consolidated Net Income since fiscal Q2 2025.
- Business Quant data shows REPL's Consolidated Net Income at -$68.87 million (Q1 2027), -$73.17 million (Q4 2026) and -$70.93 million (Q3 2026) in the three fiscal quarters before Q2 2027.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 6.45 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 210.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 4.22 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.07 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 3.12 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 3.86 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 2.43 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 3.25 Bn |
| 10 | Replimune | 2.21 Bn | 1.17 Bn | - | -56.42 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -56.42 Mn |
| Jun 30, 2026 | -68.36 Mn |
| Mar 31, 2026 | -73.17 Mn |
| Dec 31, 2025 | -70.93 Mn |
| Sep 30, 2025 | -81.57 Mn |
| Jun 30, 2025 | -86.66 Mn |
| Mar 31, 2025 | -74.14 Mn |
| Dec 31, 2024 | -66.37 Mn |
| Sep 30, 2024 | -53.06 Mn |
| Jun 30, 2024 | -53.77 Mn |
| Mar 31, 2024 | -55.05 Mn |
| Dec 31, 2023 | -51.15 Mn |
| Sep 30, 2023 | -60.04 Mn |
| Jun 30, 2023 | -49.56 Mn |
| Mar 31, 2023 | -49.25 Mn |
| Dec 31, 2022 | -39.69 Mn |
| Sep 30, 2022 | -43.10 Mn |
| Jun 30, 2022 | -42.25 Mn |
| Mar 31, 2022 | -31.30 Mn |
| Dec 31, 2021 | -29.06 Mn |
API Access
Replimune Consolidated Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=REPL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "consolidated-net-income", "ticker": "REPL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=consolidated-net-income&ticker=REPL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();